Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Busulfan, cyclophosphamide, antithymocyte globulin
(D00287)		1件: Busulfan1件: Busulfan 💬 --2件: 19, 20 💬
2Busulfan, cyclophosphamide, ATG
(D00287)		1件: Busulfan1件: Busulfan 💬 --1件: 19 💬
3Busulfan, cyclophosphamide, ATG, gcsf
(D00287)		1件: Busulfan1件: Busulfan 💬 --2件: 65, 284 💬
4CABA-201 following preconditioning with fludarabine and cyclophosphamide
(D00287)		----1件: 50 💬
5Campath, fludarabine, cyclophosphamide
(D00287)		----2件: 65, 284 💬
6Cyclophosphamide
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
7Cyclophosphamide + pred
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 283 💬
8Cyclophosphamide 100 MG/KG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 19, 222 💬
9Cyclophosphamide 100MG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
10Cyclophosphamide 1200 MG/KG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 19, 222 💬
11Cyclophosphamide 150MG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
12Cyclophosphamide 50MG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
13Cyclophosphamide 50MG oral tablet
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 162 💬
14Cyclophosphamide added TO standard immunosuppressive therapy with herombopag
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
15Cyclophosphamide and ATG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
16Cyclophosphamide and fludarabine
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--3件: 11, 13, 16 💬
17Cyclophosphamide and steroids
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 222 💬
18Cyclophosphamide dose level 1
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
19Cyclophosphamide dose level 2
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
20Cyclophosphamide dose level 3
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
21Cyclophosphamide dose level 4
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
22Cyclophosphamide followed BY methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 44 💬
23Cyclophosphamide injection 1G
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--3件: 50, 51, 52 💬
24Cyclophosphamide LD
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 49 💬
25Cyclophosphamide monohydrate
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--4件: 13, 60, 96, 256 💬
26Cyclophosphamide post transplant
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 65 💬
27Cyclophosphamide, azathioprine,prednisone,methylprednisolone
(D00287)		2件: Cyclophosphamide,
Prednisone		3件: Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
28Cyclophosphamide, bortezomib, and dexamethasone (cybord) regimen
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 28 💬
29Cyclophosphamide, fludarabine
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 285 💬
30Cyclophosphamide, fludarabine, rabbit ATG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
31Cyclophosphamide, fludarabine, thymoglobulin
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
32Cyclophosphamide,campath IH and TBI
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
33Cyclophosphamide,cyclosporine A
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
34Cyclophosphamide-prednisone-azathioprine
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 49 💬
35Cyclophosphamide/ATG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
36Cyclophosphamide/azathioprine
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 44 💬
37Cyclophosphamide/glatiramer acetate
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
38Cyclophosphamide/rituximab
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
39Dexamethasone cyclophosphamide pulse therapy
(D00287)		1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
40Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase
(D00287)		1件: Doxorubicin2件: Doxorubicin hydrochloride ,
Doxorubicin 💬 		--1件: 65 💬
41Fludarabine, cyclophosphamide
(D00287)		1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
42Glucocorticoid combined with cyclophosphamide induction + maintenance
(D00287)		----1件: 222 💬
43HIGH-dose cyclophosphamide
(D00287)		----1件: 96 💬
44IV cyclophosphamide
(D00287)		----1件: 51 💬
45Lenalidomide, dexamethasone and cyclophosphamide
(D00287)		1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
46Oral prednisolone and cyclophosphamide
(D00287)		----1件: 222 💬
47Prednisolone plus cyclophosphamide
(D00287)		1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
48Prednisone and cyclophosphamide
(D00287)		1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
49Prednisone plus cyclophosphamide
(D00287)		1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
50Prednisone, cyclophosphamide
(D00287)		1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 40 💬
51Prednisone,methylprednisone and cyclophosphamide
(D00287)		1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
52Reduced dose OF cyclophosphamide combined with standard immunosuppressive therapy
(D00287)		----1件: 60 💬
53Rituximab and cyclophosphamide IV
(D00287)		1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 35 💬
54Rituximab, cyclophosphamide, and corticosteroids
(D00287)		1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
55Thalidomide, cyclophosphamide and prednisone
(D00287)		1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 331 💬